Study on CBD and learning for generalized anxiety
Part of Mental health clinical trials.
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Right-handed
- Aged 18 to 45 years
- Diagnosed with generalized anxiety disorder or high anxiety scores
- In good general health with no major medical or brain conditions
- No use of cannabis or CBD products in the past month
- No current or recent psychotherapy or anxiety medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
This study observes people with generalized anxiety disorder to learn more about the condition. It may help improve future treatments.
This study tests a gentle brain stimulation method called High-Definition Transcranial Electrical Stimulation (HD-tES) to see if it can help reduce anxiety symptoms in people with Generalized Anxiety Disorder. It uses small electrodes on the scalp to deliver mild electrical currents to areas of the brain involved in anxiety, without surgery or major side effects.
This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.
Hear when a new Anxiety Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.